MARKET

SDGR

SDGR

Schrodinger, Inc.
NASDAQ
24.04
-0.77
-3.10%
After Hours: 24.50 +0.46 +1.91% 19:42 04/24 EDT
OPEN
24.73
PREV CLOSE
24.81
HIGH
24.86
LOW
24.02
VOLUME
568.02K
TURNOVER
0
52 WEEK HIGH
59.24
52 WEEK LOW
20.76
MARKET CAP
1.74B
P/E (TTM)
44.27
1D
5D
1M
3M
1Y
5Y
Moderna and OpenAI in pact to fast-track drug development
Healthcare Tech Moderna and OpenAI in pact to fast-track drug development. About 3,000 employees at Massachusetts-based biotech Moderna will have access to AI firm's ChatGPT Enterprise. Moderna has partnered with AI firm OpenAI to deploy the technology across its business.
Seeking Alpha · 1d ago
Weekly Report: what happened at SDGR last week (0415-0419)?
Weekly Report · 3d ago
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger, Inc. Granted stock options to nine newly hired employees on April 15, 2024. The company's physics-based computational platform is transforming the way therapeutics and materials are discovered. The stock options have a ten-year term and vest over four years.
Barchart · 04/18 07:30
Analysts See 19% Upside For IJS
NASDAQ · 04/16 10:36
Weekly Report: what happened at SDGR last week (0408-0412)?
Weekly Report · 04/15 09:08
R1 RCM, Health Catalyst downgraded as KeyBanc reviews health-tech space
R1 RCM, Health Catalyst downgraded as KeyBanc Capital Markets downgrades the stocks ahead of Q1 earnings. The firm upgraded GoodRx Holdings and Certara ahead of the healthcare IT space. The analyst cited the recent cybersecurity incident at UnitedHealth's Change Healthcare unit.
Seeking Alpha · 04/10 16:56
Press Release: Schrödinger to Announce First Quarter 2024 Financial Results on May 1
Schrödinger to Announce First Quarter 2024 Financial Results on May 1, 2024. The company will host a conference call and webcast at 4:30 p.m. ET. Schrödinging's physics-based computational platform is transforming the way therapeutics and materials are discovered.
Dow Jones · 04/10 12:31
6 Under-the-Radar AI Stocks That Analysts Expect to Rally
Morgan Stanley lists 6 under-the-radar AI stocks it considers high conviction picks. The company says the market for artificial intelligence is expected to reach a market size of $2.58 trillion by 2032. These are six companies Morgan Stanley believes are worth adding to your portfolio due to the potential of AI.
Barchart · 04/10 08:24
More
About SDGR
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The Company operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.

Webull offers Schrodinger Inc stock information, including NASDAQ: SDGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SDGR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SDGR stock methods without spending real money on the virtual paper trading platform.